Market analyst Mitesh Thakkar has suggested four BUY calls for the trading session and no SELL call. Indian markets have recovered over the last few trading sessions and considering the strength in global markets, Indian markets could see higher levels. NSE Nifty has some immediate resistance levels and we could see further strength once the resistances have been crossed on a closing basis. Dow Jones closed nearly 2 percent higher on Friday.

Crude prices have firmed up in the recent days as many regions across the world have announced easing of lockdowns. With higher demand for crude and lower production levels, energy market experts are expecting crude to remain strong. We might not see the level under USD 20 per barrel anytime soon, unless the situation about coronavirus gets worse.

Mitesh Thakkar has two pharmaceutical companies on his radar for the trading session. Thakkar suggests BUY Call for Cadila Healthcare with a stop loss of Rs 312, target at Rs 343. Thakkar has also given BUY Call for Sun Pharma with a stop loss of Rs 462.5, target at Rs 484

Thakkar has suggested BUY Call for HDFC Life. Technical analyst Sudarshan Sukhani has also suggested BUY Call for HDFC Life for today’s session. Traders can BUY HDFC Life with a stop loss of Rs 511, target at Rs 537.

Traders can also initiate a Buy trade in STR Tech with a stop loss of Rs 92, target at Rs 100. Please keep a strict stop loss for all the trades. TopNews will review the performance of trading calls by the end of the trading session.